Institute of Animal Health, Welfare and Nutrition, Aarhus University, 8830 Tjele, Denmark.
J Anim Sci. 2010 Jan;88(1):202-13. doi: 10.2527/jas.2009-1976. Epub 2009 Sep 25.
In swine nutrition, little is known about the vitamin D requirements for reproductive processes and bone health. Consequently, the vitamin D recommendation for sows during gestation and lactation is not based on scientific reports. The current study was undertaken to obtain information on the dose-response pattern of 2 vitamin D sources, the commonly used cholecalciferol, called vitamin D(3), and a newly developed Hy.D product (25-hydroxycholecalciferol). In Exp. 1, a total of 160 gilts were randomly assigned from the first estrus until d 28 of gestation to dietary treatments containing 4 concentrations of 1 of the 2 different vitamin D sources [200, 800, 1,400, and 2,000 IU/kg of vitamin D from cholecalciferol or corresponding doses of 5, 20, 35, and 50 microg/kg of feed from 25(OH)D(3) (Hy.D)]. In a concurrent experiment, the same 8 dietary treatments were provided to 160 multiparous sows from the first day of mating until weaning. Plasma concentrations of 25(OH)D(3) were influenced by a dose x form interaction (P < 0.001); furthermore, plasma 25(OH)D(3) concentrations were influenced by the lactation state of the sows. Irrespective of the dietary dose and form of vitamin D provided to the sows, very little vitamin D was transferred to the progeny. Reproductive performance was not influenced by dietary vitamin D treatments, except for a decreased number of stillborn piglets (P = 0.03, SE = 0.40) with the larger doses of vitamin D (1,400 and 2,000 IU of vitamin D, resulting in 1.17 and 1.13 stillborn piglets per litter, respectively) compared with the smaller doses of vitamin D (200 and 800 IU of vitamin D, resulting in 1.98 and 1.99 stillborn piglets per litter, respectively). In the gilt trial, the ultimate strength of the bones (P = 0.01) and their content of ash (P = 0.02) were greater when vitamin D(3) was supplemented in doses larger than 800 IU, compared with the same amount of Hy.D supplementation. In the sow experiment, lactation day (P < 0.001), rather than dietary vitamin D, influenced the concentrations of osteocalcin and Ca as well as the activities of total alkaline phosphatase and bone alkaline phosphatase in plasma. Age of the suckling piglets affected their plasma bone health markers. In conclusion, at doses greater than 200 IU, Hy.D was more bioavailable than vitamin D(3) and, as such, could be considered an equivalent or even more advantageous source of vitamin D. In addition, a dietary dose of approximately 1,400 IU of vitamin D is recommended for reproducing swine. Irrespective of the dietary dose and form of vitamin D provided to the sows, very little vitamin D was transferred to the progeny.
在猪的营养中,人们对生殖过程和骨骼健康所需的维生素 D 知之甚少。因此,妊娠和哺乳期母猪的维生素 D 推荐量不是基于科学报告。本研究旨在获得两种维生素 D 来源的剂量反应模式的信息,这两种来源是常用的胆钙化醇,称为维生素 D(3),和一种新开发的 Hy.D 产品(25-羟胆钙化醇)。在实验 1 中,总共 160 头后备母猪从第一次发情期到妊娠第 28 天被随机分配到含有 4 种不同浓度的 1 种或 2 种不同维生素 D 源的日粮处理中[200、800、1400 和 2000 IU/kg 胆钙化醇或相应剂量的 5、20、35 和 50μg/kg 饲料的 25(OH)D(3)(Hy.D)]。在一个平行实验中,同样的 8 种日粮处理被 160 头经产母猪从配种第一天到断奶期间提供。25(OH)D(3)的血浆浓度受剂量 x 形式相互作用的影响(P < 0.001);此外,母猪的泌乳状态也影响血浆 25(OH)D(3)浓度。无论母猪日粮中维生素 D 的剂量和形式如何,都很少有维生素 D 转移到后代身上。除了较大剂量的维生素 D(1400 和 2000 IU 的维生素 D,导致每窝死产仔猪分别为 1.17 和 1.13 头)与较小剂量的维生素 D(200 和 800 IU 的维生素 D,导致每窝死产仔猪分别为 1.98 和 1.99 头)相比,产仔数减少(P = 0.03,SE = 0.40),否则,日粮维生素 D 处理对繁殖性能没有影响。在后备母猪试验中,与相同剂量的 Hy.D 补充相比,当胆钙化醇的补充剂量大于 800 IU 时,骨骼的最终强度(P = 0.01)和灰分含量(P = 0.02)更大。在母猪试验中,哺乳期天数(P < 0.001)而不是日粮维生素 D 影响了骨钙素和 Ca 的浓度以及总碱性磷酸酶和血浆骨碱性磷酸酶的活性。哺乳仔猪的年龄影响了它们的血浆骨骼健康标志物。总之,在剂量大于 200 IU 时,Hy.D 比维生素 D(3)更具有生物利用度,因此可以被认为是一种等效甚至更有利的维生素 D 来源。此外,建议繁殖猪的日粮维生素 D 剂量约为 1400 IU。无论母猪日粮中维生素 D 的剂量和形式如何,都很少有维生素 D 转移到后代身上。